VC Dekho
InvestorsFundsToolsUnlocked Emails
VC Dekho
VC Dekho
InvestorsFundsToolsUnlocked Emails
Sign inUnlock investor emails free
VC Dekho
←Back to Portfolio lookup
Home›Portfolio lookup›Medibuddy
02
Portfolio lookup

Medibuddy

2 funds on VC Dekho list Medibuddy in their portfolio · HealthTech, Healthcare · Early Stage.

2backing funds
Search another companyRank funds by stage & sector
Backing funds

Who backed Medibuddy

Accelerator

GSF

Early Stage

$50K – $250K
Venture Capital

Rebright Partners

Portfolio listing

$500K – $5M
Related

Related companies

Other startups sharing a backer, sector, or stage with Medibuddy.

50FinAdopt AIAdskomAquaconnectArivihanBeacon.liBeautywiseBreathe Wellbeing
Widen the list

Funds with similar portfolios

Funds that don't back Medibuddy directly, but invest in similar sectors and stages.

Accelerator

Upekkha

SaaS / Enterprise

$100K – $250K
Private Equity

Avendus

Consumer / D2C

$10M – $100M
Corporate / CVC

Prosus Ventures

Fintech, Consumer / D2C, Edtech

$1M – $50M
Venture Capital

Unicorn India Ventures

SaaS / Enterprise, Fintech, Climate / Sustainability

$1M – $10M
Accelerator

100Unicorns

SaaS / Enterprise, Fintech, Consumer / D2C

$250K – $3M
Venture Capital

Accion Venture Lab

Fintech, Social Impact

$200K – $1M

Things to remember

FAQ

Coverage notes for Medibuddy and how to widen your search.

01How complete is the portfolio data?
VC Dekho tracks portfolio companies mentioned in fund profiles and public deal coverage. Coverage is incomplete and skews toward funds and deals with public disclosure, not a full cap table view.
02Can I search by sector instead of company name?
Not yet in this tool. Browse funds by sector or stage on the directory instead.
03How is this different from the investor matcher?
The investor matcher ranks funds by your stage, sector, and cheque size. Portfolio lookup starts from a company you already know and shows which funds backed it, plus funds with similar portfolio patterns.
04Does a listing mean the fund endorses my startup?
No. This only shows that a company appears in a fund's public portfolio or deal coverage. It is a research starting point, not an introduction or an endorsement.
Explore
Investor directoryFundsPre-seedSeedSeries APricing